Introduction
============

Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is one of the most common congenital malformations among live births worldwide[@B5]. The prevalence of NSCL/P is about 1.7 *per* 1000 live births, although this rate is different in terms of geographical position and ethnicity[@B18], with higher occurrence in Asian and Native American populations than in African populations. Although the exact etiology of NSCL/P is unknown, it is proposed that both genetic and environmental factors play a role in the disease\'s pathogenesis[@B5].

Wnts are a family of signaling molecules that play critical roles in diverse aspects of craniofacial development. The AXIN2 (axis inhibition protein 2) acts as a tumor suppressor gene in numerous cancers mapped at human chromosome 17q23-q24[@B6]. AXIN2 serves as a scaffolding component of the multiprotein complex and negatively regulates Wnt/β-catenin, signaling downstream pathway via degradation of β-catenin[@B2]. It has been shown that members of the Wnts gene family are associated with clefts in humans and mice[@B11]. Mutations or polymorphisms in AXIN2 have been shown to be associated with increased susceptibility to cancer[@B9] ^,^ [@B10] and familial tooth agenesis[@B10] ^,^ [@B16].

Bone morphogenetic proteins (BMPs) are secreted signaling molecules that belong to the transforming growth factor-b (TGF-b) superfamily of growth factors. The bone morphogenetic protein 4 (BMP4) gene is located at chromosome 14q22-23, contains four exons, and encodes the BMP4 protein[@B28], which play critical roles in embryonic development. Animal models indicated that the BMP4 is a potential candidate gene for NSCL/P[@B14]. Liu, et al.[@B13] (2005) reported that all embryos of BMP4 knockout in a mouse model had bilateral CL at the 12^th^ embryonic day, demonstrating that the BMP signal pathway is critical for cell proliferation and fusion of oral and maxillofacial construction. The rs17563 (538T/C) functional polymorphism of the BMP4 gene is shown to be associated with risk of NSCL/P development [@B7].

The interferon regulatory factor 6 (IRF6) gene is located on chromosome 1q32.2. It has been shown that variants of the IRF6 gene increased the risk of NSCL/P as well as tooth agenesis[@B20] ^,^ [@B22] ^,^ [@B26].

Genetic risk factors for NSCL/P may be attributed to ethnic and environmental differences among various populations. Accordingly, repeating previously described genetic associations in different populations is required to define the associations of the genetic risk in each population. Therefore, this study aimed to evaluate the possible association among AXIN2 rs7224837, BMP4 rs17563, and IRF6 rs861019 and 2235371 polymorphisms and NSCL/P risk in a sample of the southeast Iranian population.

Materials and Methods
=====================

A total of 288 subjects, including 132 NSCL/P and 156 healthy subjects, were recruited for this case-control study. The criteria for participants with NSCL/P and healthy individuals were previously described[@B22] ^-^ [@B24]. The local Ethics Committee of the Zahedan University of Medical Sciences approved the project (IR.ZAUMS.Rec.1393.6923) and informed consent forms were collected from all participants (or their legal guardians). Blood samples were collected in EDTA containing tubes from patients and controls, and then stored at -20°C. Genomic DNA was extracted by salting-out method.

Genotyping
----------

Genotyping of AXIN2, BMP4 and IRF6 variants was carried out using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The primers sequences and amplicon sizes are shown in [Table 1](#t1){ref-type="table"}. PCR was performed using commercially available Prime Taq premix (Genetbio, South Korea) according to the manufacturer\'s recommended protocol. Into each 0.20 ml PCR reaction tube, 1 μl of genomic DNA (\~100 ng/ml), 1 μl of each primer (10 μΜ), 10 μl of 2X Prime Taq Premix, and 7 μl of ddH20 were added. PCR cycling conditions were initial denaturation at 95°C for 5 min followed by 30 cycles for 30 s at 95°C, and annealing temperature ([Table 1](#t1){ref-type="table"}) for 30 s, extension at 72°C for 30 s, with a final extension of 72°C for 10 min. The PCR products (10 μl) were digested by appropriate restriction enzymes ([Table 1](#t1){ref-type="table"}) and the digested products were electrophoresed on 2.5% agarose gel containing 0.5 μg/mL ethidium bromide and visualized on a UV transilluminator ([Figure 1](#f1){ref-type="fig"}).

###### Genotype and allele frequencies of AXIN2, BMP4, and IRF6 polymorphisms in CL/P and control subjects

  Polymorphism           NSCL/P       Control Patients   OR (95%CI)         P-value
  ---------------------- ------------ ------------------ ------------------ ----------
  AXIN2 rs7224837 A\>G                                                      
  Codominant                                                                
  AA                     103 (78.0)   125 (80.1)         1                  \-
  AG                     25 (19.0)    26 (16.7)          1.17 (0.63-2.14)   0.643
  GG                     4 (3.0)      5 (3.2)            0.97 (0.25-3.71)   0.973
  Dominant                                                                  
  AA                     103 (78.0)   125 (80.1)         1                  \-
  AG+GG                  29 (22.0)    31 (19.9)          1.14 (0.64-2.01)   0.665
  Reccessive                                                                
  AA+AG                  128 (97.0)   151 (96.8)         1                  
  GG                     4 (3.0)      5 (3.2)            0.94 (0.25-3.59)   0.944
  Overdominant                                                              
  AA+GG                  107 (81.0)   130 (83.3)         1                  \-
  AG                     25 (19.0)    26 (16.7)          1.17 (0.64-2.14)   0.644
  Allele                                                                    
  A                      231 (87.5)   276 (88.4)         1                  \-
  G                      33 (12.5)    36 (11.6)          1.09 (0.66-1.81)   0.797
  BMP4 rs17563                                                              
  Codominant                                                                
  CC                     121 (91.7)   120 (76.9)         1                  \-
  CT                     10 (7.6)     27 (17.3)          0.36 (0.17-0.79)   0.012
  TT                     1 (0.7)      9 (5.8)            0.11 (0.01-0.88)   0.019
  Dominant                                                                  
  CC                     121 (91.7)   120 (76.9)         1                  \-
  CT+TT                  11 (8.3)     36 (23.1)          0.30 (0.15-0.62)   0.0007
  Recessive                                                                 
  CC+CT                  131 (99.3)   147 (94.2)         1                  \-
  TT                     1 (0.7)      9 (5.8)            0.12 (0.02-0.99)   0.023
  Overdominant                                                              
  CC+TT                  122 (92.4)   129 (82.7)         1                  \-
  CT                     10 (7.6)     27 (17.3)          0.39 (0.18-0.84)   0.021
  Allele                                                                    
  C                      252 (95.4)   267 (85.6)         1                  \-
  T                      12 (4.6)     45 (14.4)          0.28 (0.15-0.55)   \<0.0001
  IRF6 rs861019 G\>A                                                        
  Codominant                                                                
  GG                     54 (40.9)    50 (32.1)          1                  \-
  GA                     63 (47.7)    86 (55.1)          0.68 (0.41-1.12)   0.157
  AA                     15 (11.4)    20 (12.8)          0.69 (0.32-1.50)   0.435
  Dominant                                                                  
  GG                     54 (40.9)    50 (32.1)          1                  \-
  GA+AA                  78 (59.1)    106 (67.9)         0.68 (0.42-1.01)   0.139
  Recessive                                                                 
  GG+GA                  117 (88.6)   136 (87.2)         1                  \-
  AA                     15 (11.4)    20 (12.8)          0.87 (0.43-1.78)   0.722
  Overdominant                                                              
  GG+AA                  69 (52.3)    70 (44.9)          1                  \-
  GA                     63 (47.7)    86 (55.1)          0.74 (0.47-1.83)   0.237
  Allele                                                                    
  G                      171 (64.8)   186 (59.6)         1                  \-
  A                      93 (35.2)    126 (40.4)         0.80 (0.57-1.27)   0.228

![The primers and restriction enzymes used for detection of AXIN2, BMP4, and IRF6 polymorphisms using PCR-RFLP methods](1678-7757-jaos-25-06-0650-gf01){#f1}

Statistical analysis
--------------------

All statistical analyses were performed using the SPSS 22.0 software. The associations between alleles or genotypes and NS-CL/P were assessed by computing the odds ratio (OR) and 95% confidence intervals (95%CI) from unconditional logistic regression analyses. P-values less than 0.05 were considered statistically significant.

Results
=======

This study consisted of 132 NSCL/P (78 males, 54 females, age: 12.13±11.68 years) and 156 healthy individuals (94 males, 62 females, age: 11.35±11.81 years). Of the 132 patients, 52 had CL, 44 had CL with CP (CLP), and 36 had CP. There were no statistically significant differences between the groups regarding sex and age (p=0.904 and p=0.575, respectively). Genotypic and allelic frequencies of AXIN2, BMP4 and IRF6 polymorphisms are shown in [Table 2](#t2){ref-type="table"}.

###### Frequency distribution of genotypes combinations for the IRF6 rs861019, and BMP4 rs17563, and AXIN2 rs7224837polymorphisms between patients with nonsyndromic cleft lip and/or cleft palate (NSCL/P) and control subjects

  IRF6 rs861019   BMb4 rs17563   Axin2 rs7224837   Cases       Controls    OR (95%CI)          p
  --------------- -------------- ----------------- ----------- ----------- ------------------- -------
  GG              CC             AA                41 (31.1)   35 (22.4)   1                   \-
  GA              CC             AA                44 (33.6)   51 (32.7)   0.74 (0.40-1.35)    0.357
  AA              CC             AA                11 (8.3)    10 (6.4)    0.94 (0.36-2.47)    0.939
  GG              CT             AA                2 (1.5)     5 (3.2)     0.34 (0.06-1.87)    0.254
  GA              CC             AG                12 (9.1)    9 (5.8)     1.14 (0.43-3.02)    0.945
  GA              CT             AA                4 (3.0)     15 (9.6)    0.23 (0.07-0.75)    0.013
  GG              CC             AG                7 (5.3)     4(2.6)      1.49 (0.40-5.53)    0.747
  GG              TT             AA                1 (0.8)     4(2.6)      0.21 (0.02-2.00)    0.19
  AA              CC             AG                3 (2.3)     7 (4.5)     0.36 (0.09-1.52)    0.191
  GG              CT             AG                1 (0.8)     1 (0.6)     0.85 (0.05-14.16)   0.912
  GA              CT             AG                1 (0.8)     3 (1.9)     0.28 (0.03-2.86)    0.341
  AA              CT             AG                1 (0.8)     1 (0.6)     0.85 (0.05-14.16)   0.912
  GG              CC             GG                2(1.5)      1 (0.6)     1.71 (0.15-19.65)   0.933
  GA              CC             GG                1 (0.8)     2 (1.3)     0.42 (0.04-4.91)    0.597
  GA              CT             GG                1 (0.8)     1 (0.6)     0.85 (0.05-14.16)   0.912
  AA              CC             GG                0 (0.0)     1 (0.6)     \-                  \-
  AA              CT             AA                0 (0.0)     1 (0.6)     \-                  \-
  GA              TT             AA                0 (0.0)     4(2.6)      \-                  \-
  GA              TT             AG                0 (0.0)     1 (0.6)     \-                  \-

The findings revealed that BMP4 rs17563 polymorphism significantly decreased the risk of NSCL/P in codominant (OR=0.36, 95%CI=0.17-0.79, p = 0.012, CT vs CC and OR=0.11, 95%CI = 0.01­ 0.88, p = 0.019, TT vs CC), dominant (OR=0.30, 95%CI=0.15-0.62, p=0.0007, CT+TT vs CC), recessive (OR=0.12, 95%CI = 0.02-0.99, p = 0.023, TT vs CC+CT), and overdominant (OR=0.39, 95%CI=0.18-0.84, p=0.021, CT vs CC+TT) inheritance models. The T allele significantly decreased the risk of NSCL/P (OR=0.28, 95%CI=0.15-0.55, p\<0.0001), compared to the C allele.

Our findings did not support an association between AXIN2 rs7224837 and IRF6 rs861019 polymorphisms and risk/protection of CL/P in any inheritance model tested ([Table 1](#t1){ref-type="table"}). In addition, The IRF6 rs2235371 variant was not polymorphic and all cases (including controls) were CC genotype.

We also analyzed gene-gene interaction ([Table 2](#t2){ref-type="table"}). In comparison to the reference IRF6 rs861019 GG, BMP4 rs17563 CC, AXIN2 rs7224837 CC, and the GA/CT/AA genotype significantly decreased the risk of NSCL/P (OR=0.23, 95%CI = 0.07-0.75, p=0.013).

We also stratified the patients into cleft lip (CL), cleft lip with cleft palate (CLP), and cleft palate (CP) and assessed the impact of the polymorphisms and the risk of the disease by comparing with the controls ([Table 3](#t3){ref-type="table"}). The findings showed that the BMP4 rs17563 variant was significantly associated with decrease risk of CL, CLP, and CP. AXIN2 rs7224837 and IRF6 rs861019 were not associated with the risk of CL, CLP, or CP.

###### Genotype and allele frequencies of AXIN2 rs7224837, BMP4 rs17563, and IRF6 rs861019 gene polymorphisms in subjects with cleft lip (CL), cleft lip with cleft palate (CLP), and cleft palate (CP)

  Polymorphism      Controls   CL   OR (95%CI), p             CLP   OR (95%CI), p2             CP   OR (95%CI), p3
  ----------------- ---------- ---- ------------------------- ----- -------------------------- ---- -------------------------
  Axin2 rs7224837                                                                                   
  AA                125        41   1                         35    1                          27   1
  AG                26         9    1.06 (0.46-2.44), 0.953   7     0.96 (0.38-2/40), 0.911    9    1.60 (0.67-3.81), 0.341
  GG                5          2    1.22 (0.23-6.53), 0.917   2     1.43 (0.27-7.68), 0.651    0    \-
  A                 276        91   1                         77    1                          63   1
  C                 36         13   1.09 (0.56-2.16), 0.861   11    1.09 (0.53-2.25), 0.851    9    1.09 (0.50-2.39), 0.839
  BMP4 rs17563                                                                                      
  CC                120        48   1                         39    1                          34   1
  CT                27         3    0.28 (0.08-0.96), 0.040   5     0.57 (0.21-1.58), 0.360    2    0.26 (0.06-1.16), 0.074
  TT                9          1    0.28 (0.03-2.54), 0.288   0     3.05 (0.06-156.4), 0.983   0    0.18 (0.01-3.24), 0.206
  C                 267        99   1                         83    1                          70   1
  T                 45         5    0.30 (0.12-0.78), 0.008   5     0.36 (0.14-0.93), 0.028    2    0.17 (0.04-0.72), 0.005
  IRF6 rs861019                                                                                     
  GG                50         22   1                         14    1                          18   1
  GA                86         25   0.66 (0.34-1.29), 0.231   25    1.04 (0.49-2.18), 0.912    13   0.42 (0.19-0.93), 0.042
  AA                20         5    0.57 (0.19-1.71), 0.438   5     0.89 (0.28-2.81), 0.927    5    0.69 (0.23-2.13), 0.598
  G                 186        69   1                         53    1                          49   1
  A                 126        35   0.75 (0.47-1.19), 0.246   35    0.98 (0.60-1.58), 0.965    23   0.69 (0.40-1.19), 0.227
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Discussion
==========

The documentation of risk factors according to ethnicity and geographic origin is important for understanding the major causes of NSCL/P.

We have previously shown an association between FGF1 rs34010, CDH1 rs16260, MSX1 rs12532 and DHFR 19-bp insertion/deletion polymorphisms and NSCL/P in a sample of the southeast Iranian population[@B22] ^-^ [@B24]. In this study, we examined the impact of AXIN2, BMP4 and IRF6 polymorphisms on the risk of NSCL/P. The results suggested that BMP4 rs17563 polymorphism significantly decreased the risk of NSCL/P in codominant, dominant, recessive, and allele inheritance models. No significant association was found between AXIN2 rs7224837 and IRF6 rs861019 variants and risk of NSCL/P. We observed that rs2235371 polymorphism of the IRF6 gene was not polymorphic, and all cases (including controls) were CC genotype.

Letra, et al.[@B12] (2012) have shown a significant association between AXIN2 rs7224837 variant and risk of NSCL/P in various populations, including Latin America, Europe, and Asia. Mostowska, et al.[@B19] (2012) have found that rs3923087 polymorphism was associated with decreased risk of NSCL/P in a Polish population. However, they did not find an association between rs4074947, rs7224837, and rs2240308 variants of AXIN2 and the risk of the disease. A meta-analysis performed by Wang, et al.[@B30] (2012) showed that rs2235371 variant significantly decreased the risk of NSCL/P. Recently, Machado, et al.[@B15] (2017) showed that the minor A allele of rs7210356 as and the T-G-G-A-G haplotype formed by rs7591, rs7210356, rs4791171, rs11079571, and rs3923087 polymorphisms in the AXIN2 gene were significantly associated with NSCL/P in the Brazilian population.

Mijiti, et al.[@B17] (2015) investigated the impact of several polymorphisms of the IRF6 gene on NSCL/P in Xinjiang, China. They observed that the rs7545538 variant significantly increased the risk while rs2235377, rs2235371, 209968684, rs2013162, and rs861019 variants were associated with decreased risk of NSCL/P. The other variants were not associated with risk of NSCL/P.

Several previous studies have shown that BMP4 can be implicated in the development of CL/P. A meta-analysis performed by Hu, et al.[@B7] (2015) showed that the BMP4 rs17563 variant could play a different role in NSCL/P according to ethnicity diversity. In the Chinese population, this variant significantly increased the risk of NSCL/P while it presented a protective effect in the Brazilian population[@B1] ^,^ [@B7]. On the other hand, Chen, et al.[@B4] (2012) reported that this variant was not associated with NSCL/P in an Asian population.

The association of IRF6 rs2235371 polymorphism and NSCL/P has been extensively investigated, but the findings are still controversial[@B3] ^,^ [@B8] ^,^ [@B17] ^,^ [@B20] ^,^ [@B21] ^,^ [@B27] ^,^ [@B29]. Tang, et al.[@B27] (2009) reported that the T allele of rs2235371 may confer an increased risk of developing cleft in Chinese individuals. In contrast, another Chinese study has revealed that the rs2235371 variant appears to be protective[@B17]. In this study, we found that this variant is not polymorphic in our population. It has been reported that 12% of the genetic contributions to CL/P is related to IRF6 variants. The rs2235371 variant of IRF6 was established to increase the rate of recurrence of cleft condition to 9%[@B33]. Souza, et al.[@B26] (2016) reported that the IRF6 G/A haplotype (rs2235371/rs642961) increased the risk for oral cleft in the Brazilian population. A meta-analysis performed by Wattanawong, et al.[@B31] (2016) showed that the IRF6 rs2235371 variant decreased the risk of NSCL/P for Asian populations but not Caucasian populations. They reported that the rs2013162 variant decreased the risk of NSCL/P in Caucasian poulations but not in Asian. In addition, the finding suggest that rs642961 and rs987525 variants of IRF6 significantly increase the risk of NSCL/P in both Asian and Caucasian populations[@B31]. Xu, et al.[@B32] (2016) found that rs2235371 and rs2013162 polymorphisms of IRF6 were associated with NSCP in the Chinese population. Recently, Salagovic, et al.[@B25] (2017) reported that the IRF6 rs642961 variant significantly increased the risk of NSCL/P in the Slovakian population.

The inconsistent results may arise from different ethnic origins, environmental differences, and the complex genetic etiology of the NSCL/P disease.

One of the limitations of this study is its relatively small sample sizes. Another limitation is that we evaluated limited variants of the AXIN2, BMP4, and IRF6. Other genetic variants of these genes should also be evaluated.

In conclusion, we performed an association study of AXIN2, BMP4 and IRF6 gene SNPs with NSCL/P in an Iranian population and the findings proposed that BMP4 rs17563 polymorphism is associated with reduced risk against NSCL/P. Future studies with larger samples from different ethnicities are needed to confirm our findings.
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